Day NC, Kumar S, Criner G, Dransfield M, et al. Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus
fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD:
results on cardiovascular safety from the IMPACT trial. Respir Res 2020;21:139.
PMID: 32503599